According to the Mounjaro FDA prescribing information, injection-site reactions redness, itching, swelling, or pain at the injection point occurred in approximately 3-7% of participants across the SURPASS clinical trials depending on dose
However, research is still ongoing to fully understand its potential uses, benefits, and risks
Products sold through this website are not intended for human or animal consumption, medical use, diagnostic use, treatment, prevention, or recreational use
Otherwise, you're gambling," he said.
Expert Support: Our expert team is available to assist with any questions or concerns regarding your purchase
Blood vessel formation begins